ISSN 1671-5411 CN 11-5329/R
Volume 19 Issue 9
Sep.  2022
Turn off MathJax
Article Contents
Please cite this article as: Satti DI, Lee YHA, Leung KSK, Hui JMH, Kot TKM, Babar A, Mahalwar G, Wai AKC, Liu T, Roever L, Tse G, Chan JSK. Efficacy of vasopressin, steroid, and epinephrine protocol for in-hospital cardiac arrest resuscitation: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. J Geriatr Cardiol 2022; 19(9): 705−711. DOI: 10.11909/j.issn.1671-5411.2022.09.002
Citation: Please cite this article as: Satti DI, Lee YHA, Leung KSK, Hui JMH, Kot TKM, Babar A, Mahalwar G, Wai AKC, Liu T, Roever L, Tse G, Chan JSK. Efficacy of vasopressin, steroid, and epinephrine protocol for in-hospital cardiac arrest resuscitation: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. J Geriatr Cardiol 2022; 19(9): 705−711. DOI: 10.11909/j.issn.1671-5411.2022.09.002

Efficacy of vasopressin, steroid, and epinephrine protocol for in-hospital cardiac arrest resuscitation: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

doi: 10.11909/j.issn.1671-5411.2022.09.002
Funds:  This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
None
*The authors contributed equally to this manuscript
More Information
  •  OBJECTIVES  To assess the effect of vasopressin, steroid and epinephrine (VSE) combination therapy on return of spontaneous circulation (ROSC) after in-hospital cardiac arrest (IHCA), and test the conclusiveness of evidence using trial sequential analysis (TSA). METHODS  The systematic search included PubMed, EMBASE, Scopus, and Cochrane Central Register of Controlled Trials. Randomized controlled trials (RCTs) that included adult patients with IHCA, with at least one group receiving combined VSE therapy were selected. Data was extracted independently by two reviewers. The main outcome of interest was ROSC. Other outcomes included survival to hospital discharge or survival to 30 and 90 days, with good neurological outcomes. RESULTS  We included a total of three RCTs (n = 869). Results showed that VSE combination therapy increased ROSC (risk ratio = 1.41; 95% CI: 1.25-1.59) as compared to placebo. TSA demonstrated that the existing evidence is conclusive. This was also validated by the alpha-spending adjusted relative risk (1.32 [1.16, 1.49], P < 0.0001). Other outcomes could not be meta-analysed due to differences in timeframe in the included studies. CONCLUSIONS  VSE combination therapy administered in cardiopulmonary resuscitation led to improved rates of ROSC. Future trials of VSE therapy should evaluate survival to hospital discharge, neurological function and long-term survival.
  • loading
  • [1]
    Sinha SS, Sukul D, Lazarus JJ, et al. Identifying Important Gaps in Randomized Controlled Trials of Adult Cardiac Arrest Treatments: A Systematic Review of the Published Literature. Circ Cardiovasc Qual Outcomes 2016; 9: 749−756. doi: 10.1161/CIRCOUTCOMES.116.002916
    [2]
    Angelos MG, Butke RL, Panchal AR, et al. Cardiovascular response to epinephrine varies with increasing duration of cardiac arrest. Resuscitation 2008; 77: 101−110. doi: 10.1016/j.resuscitation.2007.10.017
    [3]
    Lindner KH, Brinkmann A, Pfenninger EG, et al. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993; 77: 427−435.
    [4]
    Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004; 2: 1−12. doi: 10.2174/1570161043476483
    [5]
    Chan JSK, Harky A. Trial sequential analysis in meta-analyses: a clinically oriented approach with real-world example. J Thorac Cardiovasc Surg 2021; 162: 167−173. doi: 10.1016/j.jtcvs.2020.06.063
    [6]
    Mentzelopoulos SD, Malachias S, Chamos C, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA 2013; 310: 270−279. doi: 10.1001/jama.2013.7832
    [7]
    Andersen LW, Isbye D, Kjaergaard J, et al. Effect of vasopressin and methylprednisolone vs placebo on return of spontaneous circulation in patients with in-hospital cardiac arrest: a randomized clinical trial. JAMA 2021; 326: 1586−1594. doi: 10.1001/jama.2021.16628
    [8]
    Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009; 169: 15−24. doi: 10.1001/archinternmed.2008.509
    [9]
    Shah K, Mitra AR. Use of corticosteroids in cardiac arrest-a systematic review and meta-analysis. Crit Care Med 2021; 49: e642−e650. doi: 10.1097/CCM.0000000000004941
    [10]
    Liu B, Zhang Q, Li C. Steroid use after cardiac arrest is associated with favourable outcomes: a systematic review and meta-analysis. J Int Med Res 2020; 48: 300060520921670.
    [11]
    Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 2017; 17: 39. doi: 10.1186/s12874-017-0315-7
    [12]
    Yan S, Gan Y, Jiang N, et al. The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care 2020; 24: 61. doi: 10.1186/s13054-020-2773-2
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Article Metrics

    Article views (281) PDF downloads(63) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return